3
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Lanreotide, non steroidal anti androgens and LHRH-a
"Lanreotide 120 mg. Injection every 28 days, to be administered till progression or for a maximum of 24 months.~Non steroidal anti androgens (e.g. bicalutamide 50 mg/day to be administered till progression) plus LHRH-a (e.g. triptorelin 3.75 mg/month till progression."
Non steroidal anti androgens and LHRH-a
Non steroidal anti androgens (e.g. bicalutamide 50 mg/day to be administered till progression) plus LHRH-a (e.g. triptorelin 3.75 mg/month till progression
A.O. S. Luigi Gonzaga, Orbassano ( TO)
Lead Sponsor
Ipsen
INDUSTRY